Acute liver failure in Spain: Analysis of 267 cases

被引:140
作者
Escorsell, Angels
Mas, Antoni
de la Mata, Manuel
机构
[1] Hosp Clin Barcelona, Liver Unit, Inst Clin Malalt Digest & Metab, E-08036 Barcelona, Spain
[2] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Catalonia, Spain
[3] Hosp Reina Sofia, Liver Transplant Unit, Cordoba, Spain
关键词
D O I
10.1002/lt.21119
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The cause of acute liver failure (ALF) is a major determinant of its outcome. Acetaminophen (paracetamol) overdose is a leading cause of ALF in some developed countries, whereas in others, such as Spain, it is extremely rare. To analyze the etiology, characteristics, and outcome of ALF in Spain, we performed a retrospective analysis of 267 patients whom we observed from 1992 to 2000. Seventeen tertiary-care hospitals with active liver transplantation (LT) programs contributed data. Causes of ALF were viral hepatitis in 98 (37%; hepatitis B virus in 75 patients), unknown in 86 (32%), drug or toxic reactions in 52 (19.5%; acetaminophen overdose in 6), and miscellaneous in 31 (11.6%). Overall survival was 58%. LT was performed in 150 patients, with a survival of 69%. Despite fulfilling criteria, 51 patients were not transplanted because of contraindications; their survival was only 7.8%. Forty-seven (85.5%) of 55 patients without transplant criteria survived. Hepatitis B virus is the most common cause of ALF in Spain, although the origin of 30% of cases remains undetermined. Acetaminophen overdose represents a very rare cause of ALF. LT was performed in >50% of cases. Patients without transplant criteria had a very good prognosis; those who fulfilled these criteria but who had contraindications for transplantation had a high mortality rate.
引用
收藏
页码:1389 / 1395
页数:7
相关论文
共 20 条
  • [1] Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome
    Acharya, SK
    Dasarathy, S
    Kumer, TL
    Sushma, S
    Prasanna, KSU
    Tandon, A
    Sreenivas, V
    Nijhawan, S
    Panda, SK
    Nanda, SK
    Irshad, M
    Joshi, YK
    Duttagupta, S
    Tandon, RK
    Tandon, BN
    [J]. HEPATOLOGY, 1996, 23 (06) : 1448 - 1455
  • [2] Bernal W, 2003, SEMIN LIVER DIS, V23, P227
  • [3] Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain
    Bernuau, J
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (01) : 152 - 155
  • [4] FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES
    BERNUAU, J
    RUEFF, B
    BENHAMOU, JP
    [J]. SEMINARS IN LIVER DISEASE, 1986, 6 (02) : 97 - 106
  • [5] LIVER-TRANSPLANTATION FOR ACUTE LIVER-FAILURE - ANALYSIS OF APPLICABILITY
    CASTELLS, A
    SALMERON, JM
    NAVASA, M
    RIMOLA, A
    SALO, J
    ANDREU, H
    MAS, A
    RODES, J
    [J]. GASTROENTEROLOGY, 1993, 105 (02) : 532 - 538
  • [6] PROTECTIVE AGENTS FOR ACETAMINOPHEN OVERDOSE
    DAVIS, M
    [J]. SEMINARS IN LIVER DISEASE, 1986, 6 (02) : 138 - 147
  • [7] CLINICAL AND PROGNOSTIC DIFFERENCES IN FULMINANT-HEPATITIS TYPE-A, TYPE-B AND TYPE-NON-A-NON-B
    GIMSON, AES
    WHITE, YS
    EDDLESTON, ALWF
    WILLIAMS, R
    [J]. GUT, 1983, 24 (12) : 1194 - 1198
  • [8] INTRAVENOUS ACETYLCYSTEINE IN PARACETAMOL INDUCED FULMINANT HEPATIC-FAILURE - A PROSPECTIVE CONTROLLED TRIAL
    KEAYS, R
    HARRISON, PM
    WENDON, JA
    FORBES, A
    GOVE, C
    ALEXANDER, GJM
    WILLIAMS, R
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6809) : 1026 - 1029
  • [9] Lee WM, 2003, SEMIN LIVER DIS, V23, P217
  • [10] NAVASA M, 1986, GASTROENTEROL HEPATO, V9, P221